Insight Molecular Diagnostics Inc. Selling and Marketing Expense
Insight Molecular Diagnostics Inc. (IMDX) reported Selling and Marketing Expense of $1.92 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-08-10
- Insight Molecular Diagnostics Inc. selling and marketing expense for the quarter ending 2026-06-30 was $1.92M, a 31.23% increase year-over-year.
- Insight Molecular Diagnostics Inc. selling and marketing expense for the quarter ending 2026-03-31 was $2.40M, a 99.17% increase year-over-year.
- Insight Molecular Diagnostics Inc. selling and marketing expense for the quarter ending 2025-12-31 was $2.29M, a 90.60% increase year-over-year.
- Insight Molecular Diagnostics Inc. selling and marketing expense for the quarter ending 2025-09-30 was $1.39M, a 32.89% increase year-over-year.
- Insight Molecular Diagnostics Inc. selling and marketing expense for fiscal 2025 was $6.34M, a 60.83% increase from fiscal 2024.
- Insight Molecular Diagnostics Inc. selling and marketing expense for fiscal 2024 was $3.94M, a 41.11% increase from fiscal 2023.
- Insight Molecular Diagnostics Inc. selling and marketing expense for fiscal 2023 was $2.79M, a 146.91% increase from fiscal 2022.
- Insight Molecular Diagnostics Inc. selling and marketing expense for fiscal 2022 was $1.13M, a 105.07% increase from fiscal 2021.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 3 month as first filed | Selling and Marketing Expense 6 month | Selling and Marketing Expense 6 month as first filed | Selling and Marketing Expense 9 month | Selling and Marketing Expense 9 month as first filed | Selling and Marketing Expense 12 month | Selling and Marketing Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.92M 10-Q · filed 2026-08-10 | $4.32M 10-Q · filed 2026-08-10 | $6.61M derived: sum of 3 quarters · filed 2026-08-10 | $8.00M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | $2.40M 10-Q · filed 2026-05-13 | $4.69M derived: sum of 2 quarters · filed 2026-05-13 | $6.08M derived: sum of 3 quarters · filed 2026-05-13 | $7.54M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | $2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $3.68M derived: sum of 2 quarters · filed 2026-03-26 | $5.14M derived: sum of 3 quarters · filed 2026-08-10 | $6.34M 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | $1.39M 10-Q · filed 2025-11-10 | $2.85M derived: sum of 2 quarters · filed 2026-08-10 | $4.05M 10-Q · filed 2025-11-10 | $5.25M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | $1.46M 10-Q · filed 2026-08-10 | $2.67M 10-Q · filed 2026-08-10 | $3.87M derived: sum of 3 quarters · filed 2026-08-10 | $4.91M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | $1.21M 10-Q · filed 2026-05-13 | $2.41M derived: sum of 2 quarters · filed 2026-05-13 | $3.45M derived: sum of 3 quarters · filed 2026-05-13 | $4.30M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $2.25M derived: sum of 2 quarters · filed 2026-03-26 | $3.10M derived: sum of 3 quarters · filed 2026-03-26 | $3.94M 10-K · filed 2026-03-26 | ||||
| 2024-09-30 | $1.04M 10-Q · filed 2025-11-10 | $1.90M derived: sum of 2 quarters · filed 2025-11-10 | $2.74M 10-Q · filed 2025-11-10 | $3.32M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | $853.00K 10-Q · filed 2025-08-11 | $1.70M 10-Q · filed 2025-08-11 | $2.28M derived: sum of 3 quarters · filed 2025-08-11 | $2.99M derived: sum of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | $846.00K 10-Q · filed 2025-05-12 | $1.43M derived: sum of 2 quarters · filed 2025-05-12 | $2.14M derived: sum of 3 quarters · filed 2025-05-12 | $2.95M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $582.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $1.29M derived: sum of 2 quarters · filed 2025-03-24 | $2.10M derived: sum of 3 quarters · filed 2025-03-24 | $2.79M 10-K · filed 2025-03-24 | ||||
| 2023-09-30 | $713.00K 10-Q · filed 2024-11-12 | $1.52M derived: sum of 2 quarters · filed 2024-11-12 | $2.21M 10-Q · filed 2024-11-12 | $2.55M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $805.00K 10-Q · filed 2024-08-08 | $1.50M 10-Q · filed 2024-08-08 | $1.83M derived: sum of 3 quarters · filed 2024-08-08 | $2.24M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $695.00K 10-Q · filed 2024-05-15 | $1.03M derived: sum of 2 quarters · filed 2024-05-15 | $1.43M derived: sum of 3 quarters · filed 2024-05-15 | $1.56M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $334.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $739.00K derived: sum of 2 quarters · filed 2024-04-16 | $866.00K derived: sum of 3 quarters · filed 2024-04-16 | $1.13M 10-K · filed 2024-04-16 | ||||
| 2022-09-30 | $405.00K 10-Q · filed 2023-11-09 | $4.00M 10-Q · filed 2022-11-10 | $532.00K derived: sum of 2 quarters · filed 2023-11-09 | $798.00K 10-Q · filed 2023-11-09 | $10.76M 10-Q · filed 2022-11-10 | $4.11M derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | $127.00K 10-Q · filed 2023-08-10 | $3.52M 10-Q · filed 2022-08-12 | $393.00K 10-Q · filed 2023-08-10 | $6.76M 10-Q · filed 2022-08-12 | $3.70M derived: sum of 3 quarters · filed 2023-08-10 | $6.63M derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | $266.00K 10-Q · filed 2023-05-15 | $3.24M 10-Q · filed 2022-05-12 | $3.58M derived: sum of 2 quarters · filed 2023-05-15 | $6.51M derived: sum of 3 quarters · filed 2023-05-15 | $9.18M derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | $3.31M 10-K · filed 2022-03-11 | $6.24M derived: sum of 2 quarters · filed 2022-11-10 | $8.91M derived: sum of 3 quarters · filed 2022-11-10 | $552.00K 10-K · filed 2023-04-12 | $11.17M 10-K · filed 2022-03-11 | |||
| 2021-09-30 | $2.93M 10-Q · filed 2022-11-10 | $5.60M derived: sum of 2 quarters · filed 2022-11-10 | $7.86M 10-Q · filed 2022-11-10 | $9.73M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $2.67M 10-Q · filed 2022-08-12 | $4.93M 10-Q · filed 2022-08-12 | $6.80M derived: sum of 3 quarters · filed 2022-08-12 | $8.37M derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $2.25M 10-Q · filed 2022-05-12 | $4.13M derived: sum of 2 quarters · filed 2022-05-12 | $5.70M derived: sum of 3 quarters · filed 2022-05-12 | $7.26M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $1.87M 10-K · filed 2022-03-11 | $3.44M derived: sum of 2 quarters · filed 2022-03-11 | $5.00M derived: sum of 3 quarters · filed 2022-03-11 | $6.49M 10-K · filed 2022-03-11 | ||||
| 2020-09-30 | $1.57M 10-K · filed 2022-03-11 | $3.13M derived: sum of 2 quarters · filed 2022-03-11 | $4.62M 10-Q · filed 2021-11-09 | $5.63M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2020-06-30 | $1.56M 10-K · filed 2022-03-11 | $3.05M 10-Q · filed 2021-08-11 | $4.06M derived: sum of 3 quarters · filed 2022-03-11 | $4.69M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2020-03-31 | $1.49M 10-K · filed 2022-03-11 | $2.50M derived: sum of 2 quarters · filed 2022-03-11 | $3.13M derived: sum of 3 quarters · filed 2022-03-11 | $3.45M derived: sum of 4 quarters · filed 2022-03-11 | ||||
| 2019-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19 | $1.64M derived: sum of 2 quarters · filed 2021-03-19 | $1.96M derived: sum of 3 quarters · filed 2021-03-19 | $2.16M 10-K · filed 2021-03-19 | ||||
| 2019-09-30 | $630.00K 10-Q · filed 2020-11-12 | $948.00K derived: sum of 2 quarters · filed 2020-11-12 | $1.15M 10-Q · filed 2020-11-12 | $1.42M derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | $318.00K 10-Q · filed 2020-07-29 | $523.00K 10-Q · filed 2020-07-29 | $793.00K derived: sum of 3 quarters · filed 2020-07-29 | $977.00K derived: sum of 4 quarters · filed 2020-07-29 | ||||
| 2019-03-31 | $205.00K 10-Q · filed 2020-05-12 | $475.00K derived: sum of 2 quarters · filed 2020-05-12 | $659.00K derived: sum of 3 quarters · filed 2020-05-12 | $1.23M derived: sum of 4 quarters · filed 2020-05-12 | ||||
| 2018-12-31 | $270.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $454.00K derived: sum of 2 quarters · filed 2020-03-26 | $1.02M derived: sum of 3 quarters · filed 2020-03-26 | $1.68M 10-K · filed 2020-03-26 | ||||
| 2018-09-30 | $184.00K 10-Q · filed 2019-11-14 | $753.00K derived: sum of 2 quarters · filed 2019-11-14 | $1.41M 10-Q · filed 2019-11-14 | $2.01M derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | $569.00K 10-Q · filed 2019-08-14 | $1.23M 10-Q · filed 2019-08-14 | $1.83M derived: sum of 3 quarters · filed 2019-08-14 | $2.54M derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | $658.00K 10-Q · filed 2019-05-14 | $1.26M derived: sum of 2 quarters · filed 2019-05-14 | $1.97M derived: sum of 3 quarters · filed 2019-05-14 | $2.44M derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $1.31M derived: sum of 2 quarters · filed 2019-04-01 | $1.79M derived: sum of 3 quarters · filed 2019-04-01 | $2.44M 10-K · filed 2019-04-01 | ||||
| 2017-09-30 | $710.00K 10-Q · filed 2018-11-13 | $1.19M derived: sum of 2 quarters · filed 2018-11-13 | $1.84M 10-Q · filed 2018-11-13 | $2.38M derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | $477.00K 10-Q · filed 2018-08-14 | $1.13M 10-Q · filed 2018-08-14 | $1.68M derived: sum of 3 quarters · filed 2018-08-14 | $1.83M derived: sum of 4 quarters · filed 2018-08-14 | ||||
| 2017-03-31 | $655.00K 10-Q · filed 2018-05-15 | $1.20M derived: sum of 2 quarters · filed 2018-05-15 | $1.35M derived: sum of 3 quarters · filed 2018-05-15 | $1.62M derived: sum of 4 quarters · filed 2018-05-15 | ||||
| 2016-12-31 | $543.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $699.00K derived: sum of 2 quarters · filed 2018-04-02 | $969.00K derived: sum of 3 quarters · filed 2018-04-02 | $1.20M 10-K · filed 2018-04-02 | ||||
| 2016-09-30 | $156.00K 10-Q · filed 2017-11-14 | $426.00K derived: sum of 2 quarters · filed 2017-11-14 | $655.00K 10-Q · filed 2017-11-14 | |||||
| 2016-06-30 | $270.00K 10-Q · filed 2017-08-14 | $499.00K 10-Q · filed 2017-08-14 | ||||||
| 2016-03-31 | $228.00K 10-Q · filed 2017-04-28 | |||||||
| 2015-12-31 | $324.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |